Book contents
- The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
- The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
- Copyright page
- Dedication
- Contents
- Videos
- Contributors
- Preface
- Section 1 Basic Sciences in Gynaecology
- Section 2 Menstrual Disorders
- Section 3 Reproductive Endocrinology and Infertility
- Section 4 Contraception and STIs
- Section 5 Post-Reproductive Care
- Section 6 Vulva and Vagina
- Section 7 Cervix
- Section 8 Uterus
- Chapter 35 Malignant Disease of Uterine Corpus
- Chapter 36 Uterine Sarcoma and Rare Uterine Malignant Disease
- Section 9 Ovary and Fallopian Tubes
- Section 10 Operative Gynaecology
- Section 11 Public Health Issues in Gynaecology
- Section 12 Miscellaneous
- Index
- Plate Section (PDF Only)
- References
Chapter 35 - Malignant Disease of Uterine Corpus
from Section 8 - Uterus
Published online by Cambridge University Press: 24 November 2021
Book contents
- The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
- The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
- Copyright page
- Dedication
- Contents
- Videos
- Contributors
- Preface
- Section 1 Basic Sciences in Gynaecology
- Section 2 Menstrual Disorders
- Section 3 Reproductive Endocrinology and Infertility
- Section 4 Contraception and STIs
- Section 5 Post-Reproductive Care
- Section 6 Vulva and Vagina
- Section 7 Cervix
- Section 8 Uterus
- Chapter 35 Malignant Disease of Uterine Corpus
- Chapter 36 Uterine Sarcoma and Rare Uterine Malignant Disease
- Section 9 Ovary and Fallopian Tubes
- Section 10 Operative Gynaecology
- Section 11 Public Health Issues in Gynaecology
- Section 12 Miscellaneous
- Index
- Plate Section (PDF Only)
- References
Summary
Malignant disease of uterine corpus is mostly represented by endometrial cancer, the most frequent genital tract neoplasia in developed countries, affecting women more frequently in perimenopause or after menopause.
Classically divided into type I endometrioid tumours (80–90%) and type II tumours, associated with a worse prognosis (e.g. serous, clear cell), it recently became clear that the genomic analysis of these tumours is the most accurate tool to recognize the prognosis of an endometrial neoplasia much earlier.
The diagnosis usually involves a combination of ultrasound and hysteroscopy, and the latter remains the gold standard to obtain an endometrial sample in this setting. The standard treatment and extension of the surgical staging will depend on the pre- and perioperative evaluation, including the histological type and grade, as well as the depth of myometrial invasion. The need for adjuvant therapy is currently decided by the assessment of the risk for recurrence.
- Type
- Chapter
- Information
- The EBCOG Postgraduate Textbook of Obstetrics & GynaecologyGynaecology, pp. 293 - 304Publisher: Cambridge University PressPrint publication year: 2021
References
Ayhan, A, Reed, N, Gultenkin, M, Dursun, P. Endometrial cancer epidemiology & treatment. In: Textbook of Gynaecological Oncology, 3rd edition. Ankara: Günes Publishing, 2016, pp. 529–538.Google Scholar
Colombo, N, Creutzberg, C, Amant, F, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer. Int J Gynecol Cancer 2016;26:2–30.Google Scholar
Setiawan, VW, Yang, HP, Pike, MC, et al. Type I and II endometrial cancers: have they different risk factors? JCO 2013;31:2607–2618.Google Scholar
Ayhan, A, Reed, N, Gultenkin, M, Dursun, P. Endometrial hyperplasia without atypia and endometrioid intraepithelial neoplasia (EIN). In: Textbook of Gynaecological Oncology, 3rd edition. Ankara: Günes Publishing, 2016, pp. 509–515.Google Scholar
RCOG. Management of endometrial hyperplasia. Green-top Guideline No. 67. 2016. Available at : www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg_67_endometrial_hyperplasia.pdf.Google Scholar
Berek, JS. Berek & Novak’s Gynecology, 15th edition. Philadelphia, PA: Lippincott Williams & Wilkins, 2014.Google Scholar
Morice, P, Leary, A, Creutzberg, C, Abu-Rustum, N, Darai, E. Endometrial cancer. Lancet 2018;387:1094–1108.Google Scholar
Iijima, M, Banno, K, Okawa, R, et al. Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer. Oncol Lett 2018;13:1063–1070.Google Scholar
Talhouk, A, McAlpine, JN. New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care. Gynaecol Oncol Res Pract 2018;3:14.Google Scholar
Ayhan, A, Reed, N, Gultenkin, M, Dursun, P. Use of preoperative biomarkers to identify high risk endometrial carcinoma patients. In: Textbook of Gynaecological Oncology, 3rd edition. Ankara: Günes Publishing, 2016, pp. 653–659.Google Scholar
Ayhan, A, Reed, N, Gultenkin, M, Dursun, P. Histopathology of endometrioid endometrial cancer. In: Textbook of Gynaecological Oncology, 3rd edition. Ankara: Günes Publishing, 2016, pp. 539–542.Google Scholar
Ayhan, A, Reed, N, Gultenkin, M, Dursun, P. Uterine serous carcinomas. In: Textbook of Gynaecological Oncology, 3rd edition. Ankara: Günes Publishing, 2016, pp. 565–579.Google Scholar
Ayhan, A, Reed, N, Gultenkin, M, Dursun, P. Uterine clear cell carcinomas. In: Textbook of Gynaecological Oncology, 3rd edition. Ankara: Günes Publishing, 2016, pp. 579–585.Google Scholar
Colombo, N, Preti, E, Landoni, F, et al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018;24:vi33–vi38.Google Scholar
Munro, M. Investigation of women with postmenopausal uterine bleeding: clinical practice recommendations. Perm J 2014;18:55–70.CrossRefGoogle ScholarPubMed
Koutlaki, N, Dimitraki, M, Zervoudis, S, et al. Hysteroscopy and endometrial cancer: diagnosis and influence on prognosis. Gynecol Surg 2018;7:335–341.CrossRefGoogle Scholar
Frühauf, F, Zikan, M, Semeradova, I, et al. The diagnostic accuracy of ultrasound in assessment of myometrial invasion in endometrial cancer: subjective assessment versus objective techniques. Bio Med Res Int 2017. doi: 10.1155/2017/1318203.CrossRefGoogle Scholar
Nougaret, S, Horta, M, Sala, E, et al. Endometrial cancer MRI staging: updated guidelines of the European Society of Urogenital Radiology. Eur Radiol 2018;29:792–705.CrossRefGoogle ScholarPubMed
Pecorelli, S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet 2009;105:103–104.Google Scholar
Ayhan, A, Reed, N, Gultenkin, M, Dursun, P. Conservative treatment of early endometrial cancer. In: Textbook of Gynaecological Oncology, 3rd edition. Ankara: Günes Publishing, 2016, pp. 586–593.Google Scholar
Stephan, J-M, Hansen, J, Samuelson, M, et al. Intra-operative frozen section results reliably predict final pathology in endometrial cancer. Gynecologic Oncol 2018;133:499–405.Google Scholar
Cripe, J, Handorf, E, Brown, J, et al. National Cancer Database report of lymphadenectomy trends in endometrial cancer. Int J Gynecol Cancer 2017;27:1408–1415.Google Scholar
Ramirez, PT, Frumovitz, M, Abu-Rustum, NR. Principles of Gynecologic Oncology Surgery. Philadelphia, PA: Elsevier, 2018.CrossRefGoogle Scholar
Holloway, RW, Abu-Rustum, NR, Backes, FJ, et al. Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations. Gynecologic Oncol 2017;146:405–415.Google Scholar
Bodurtha Smith, AJ, Fader, AN, Tanner, EJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol 2017;216:459–476.e10.CrossRefGoogle ScholarPubMed
Piovano, E, Fuso, L, Poma, CB, et al. Complications after the treatment of endometrial cancer. Int J Gynecol Cancer 2014;24:418–426.Google Scholar
Viswanathan, AN, Lee, LJ, Eswara, JR, et al. Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer 2014;120:3870–3883.Google Scholar
de Boer, SM, Powell, ME, Mileshkin, L, et al. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial. Lancet Oncol 2016;17:1114–1126.Google Scholar
Zhang, Y, Zhao, D, Gong, C, et al. Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis. World J Surg Oncol 2015;13.Google Scholar
Karnezis, AN, Leung, S, Magrill, J, et al. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification. J Path Clin Res 2017;3:279–293.Google Scholar